Number of Shares
1,600.00
Current Holdings Value*
$28,740.00
% of Portfolio
3.28%
Total Estimate Gain
$-2,873.00
% of Total Estimate Gain
-4.17%

VALUE LINE VIP EQUITY ADVANTAGE FUND's abrdn Life Sciences Investors Holding Summary

As of 2020-06-30, VALUE LINE FUNDS VARIABLE TRUST held 1,600.00 shares of abrdn Life Sciences Investors(HQL), totaling $28,740.00. This investment constitutes 3.28% of their stock portfolio, and VALUE LINE FUNDS VARIABLE TRUST now holds 0.01% of the outstanding abrdn Life Sciences Investors(HQL) stock.

The initial trade took place in 2019Q3. In addition, there have been 2 sales at an average price of $16.78 for 2,700.00 shares. Based on historical transaction data and HQL's current price of $12.94, VALUE LINE VIP EQUITY ADVANTAGE FUND's estimated gain on his HQL holdings is $-2,873.00, reflecting a -4.17% gain to date.

VALUE LINE VIP EQUITY ADVANTAGE FUND HQL ($12.94) Holding Chart

VALUE LINE VIP EQUITY ADVANTAGE FUND HQL ($12.94) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1